Cleveland Clinic Laboratories

Similar documents
Cleveland Clinic Laboratories

NEW IHC A n t i b o d i e s

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Technology from Abcam

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2 on all newly diagnosed cases

Charles Halsey, DVM, PhD, DACVP Pfizer, Inc. IHC Resources

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

IHC Panels as an Aid in Diagnostic Decision Making

Schedule of Accreditation issued by United Kingdom Accreditation Service High Street, Feltham, Middlesex, TW13 4UN, UK

C.L. Davis Foundation Descriptive Veterinary Pathology Course

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

The Oral Histology Series Series 5 Special Stains

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

In Situ Hybridization Immunohistochemistry

The role of immunohistochemistry in surgical pathology of the uterine corpus and cervix

Schedule of Accreditation - draft issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

The Panel Approach to Diagnostics. Lauren Hopson International Product Specialist Cell Marque Corporation

Differential diagnosis of HCC

IIImmunohistochemistry (IHC) Outreach Services

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Atlas of Stains. Special Stains on Artisan Link Pro

antibodies by application

Protocols for Zytomed Systems antibodies on fully automated IHC staining systems date of issue: September 20, 2012

TUMOR M ARKERS MARKERS

TEST MENU BY SPECIALTY

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

ADVANCED STAINING PRODUCT CATALOG. In Situ Hybridization Probes Immunohistochemistry Antibodies Detection Systems Ancillary Reagents

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

CURRENT AND EMERGING CANCER DIAGNOSTIC TESTS Emerging Assays, and Companies Developing New Technologies and Products.

Your single-source laboratory solution. Antibody Library

3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships

The impact of proficiency testing on lab immunoassays

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Tumor Markers & Cytopathology

Immunohistochemical classification of lung carcinomas and mesotheliomas. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

Bihong Zhao, M.D, Ph.D Department of Pathology

DOUBLE STAINS. Toll-Free: Direct:

Tumor Markers: Granular Analysis of the US Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests. List of Tables

Diagnostic IHC in lung and pleura pathology

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Histopathological diagnosis of CUP

Breast cancer: IHC classification. Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark

2016 Antibodies by Application

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Cutaneous metastases. Thaddeus Mully. University of California, San Francisco Professor, Departments of Pathology and Dermatology

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

CARCINOMA OF UNKNOWN PRIMARY: DIAGNOSTIC APPROACH USING IMMUNOHISTOCHEMISTRY

Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement

Immunohistochemical classification of the unknown primary tumour (UPT) Part I. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark

Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors

Nordic Immunohistochemical Quality Control

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

Classification of the unknown primary tumour: the primary IHC panel

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Reporting of carcinoma of unknown primary tumour (CUP)

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

C.L. Davis Foundation Descriptive Veterinary Pathology Course at Louisiana State University

Immunohistochemistry. Potential and challenges To be or not to be

Immunopathology of Lymphoma

immunohistochemistry stain offerings

Financial disclosures

Carcinoma of unknown primary origin (CUP) is defined

The clinically challenging entity of liver metastasis from tumors of unknown primary

Immunohistochemical classification of haematolymphoid tumours. Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

INTERPRETATION OF IMMUNOHISTOCHEMICAL STAINS - DIFFICULTIES AND PITFALLS. Gabor Fischer Diagnostic Services Manitoba University of Manitoba

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Descriptive Immunohistochemistry. Agenda. Agenda. What is Immunohistochemistry? 6/3/2014. Tissue from a dog

Single and Multiplex Immunohistochemistry

8 years later! Next Generation Sequencing. Pathogenic Findings: HNF1A c.864delinscc, p.g292rfs*25 (NM_ ) (VAF: 59%) HNF1A Loss

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Hematology Diagnostic Services

The unkown primary tumour: IHC Classification, antibody selection, protocol optimization, controls and EQA (part II)

Case: The patient is a 73 year old woman with vague complaints of dyspepsia and abdominal pain. Upper endoscopy showed features of gastritis and a

Carcinoma of Unknown Primary (CUP)

The unknown primary tumour: IHC classification part I, the primary panel - Antibody selection, protocol optimization, controls and EQA

Tumor Immunology. Tumor (latin) = swelling

External Quality Assessment of melanocytic marker analyses NordiQC experience

New Developments in Immunohistochemistry for Gynecologic Pathology

The unkown primary tumour: IHC Classification, antibody selection, protocol optimization, controls and EQA (part I)

Ascitic Fluid and Use of Immunocytochemistry. Mercè Jordà, University of Miami

Classification! Immunohistochemical classification of haematolymphoid tumours. Malignant lymphoproliferative diseases

Transcription:

Cleveland Clinic Laboratories Anatomic Pathology Special s Group I for Microorganisms Special s Group I 88312 Fite stain Gomori s methenamine silver (GMS) Gram Gridley PAS/light green counterstain Warthin-Starry Ziehl-Neelsen AFB s for mycobacteria leprae Fungus, Pneumocystis, Bacteria Gram-positive and gram-negative bacteria Fungus Fungus Bacteria, Spirochetes Acid-fast mycobacterium Group II (All Other) Special s Group II 88313 Alcian Blue, ph 2.5 Alcian Blue/Hyaluronidase Alcian Blue/PAS Bielschowsky Bile, Hall s method Bodian Colloidal iron Colloidal Iron/Hyaluronidase Congo Red Copper (Rhodanine) Crystal Violet Elastic stain (EVG) Fontana-Masson Giemsa (mast cell) Iron stain Jones methenamine silver Luxol fast blue Masson trichrome Melanin bleach Movat Mucicarmine Oil Red O PAS/amylase (PAS/D) Periodic acid-schiff (PAS) PTAH Reticulum SAB Thioflavin S Acid mucopolysaccharides Differentiation of epithelial and connective tissue mucins Acid and neutral mucins Neurofibrils Bilirubin Nerve fibers Mucopolysaccharides, Collagen Differentiation of epithelial and connective tissue mucins Copper Elastic fibers, Collagen Argentaffin granules or Melanin Eosinphilic granules and Mast cells Iron Basement membranes, Reticular fibers Myelin Collagen Eliminates melanin Elastic fibers, Collagen, Mucin, Fibrin and Muscle Mucosubstances Fat Eliminates glycogen Glycogen, Neutral mucopolysaccharides and Basement membranes Collagen, Fibrin, Coarse elastic fibrils s for reticulum fibers 9500 Euclid Avenue Cleveland, Ohio 44195 216.444.5755 800.628.6816 clevelandcliniclabs.com

Group II (All Other cont.) Special s Group II 88313 Toluidine Blue Uric acid Von Kossa Mast cell granules Urate crystals Calcium Histochemical s (Enzyme) 88319 Acetylcholinesterase (ACE) Acid phosphatase Alkaline phosphatase ATP (4.6, 9.8) Cytochrome C Esterase NADH Phosphofructokinase Phosphorylase Succinic dehydrogenase (SDH) Immunohistochemistry s Nerve fibers/hirschsprung s disease Muscle fibers undergoing degeneration Basement membranes and regenerating fibers Muscle fiber types Cytochrome oxidase Denervated muscle fibers Whorls, Target fibers, Central cores, Moth-eaten fibers PFK activity Phosphorylase activity Mitochondrial disease ACTH Human adrenocorticotropic hormone Actin HHF35 Human muscle actin Actin SM Alpha-smooth muscle isoform, Myoepithelium, etc. Adenovirus Adenovirus AFP Alpha fetoprotein ALK (D5F3) Anaplastic lymphoma kinase, clone D5F3 ALK-1 ALK-1 Kappa (AMY-K) osis Lambda (AMY-L) osis Androgen Recept Androgen Receptor Arginase 1 Identify normal liver cells ß-Catenin Beta Catenin BCL-2 Follicular lymphoma, Apoptosis inhibin protein BCL2 EP36 BCL2, clone EP36 BCL-6 Follicular and diffuse lymphomas, Burkitt s lymphoma & Lymphocyte predominant Hodgkin s disease B72.3 Tumor associated glycoprotein BOB-1 Transcription coactivator for Oct-1 and Oct-2 BRAF Hairy cell Leukemia CA9 Carbonic Anhydrase IX CA 125 Tumor marker for ovarian, endometrial, breast, GI cancer Calcitonin (CALC) Calcitonin Calponin Myoepithelial differentiation and diagnosis of myoepithelial neoplasms Calretinin (CALR) Calcium-binding protein, Mesothelial cells Cathepsin K Renal angiomyolipoma C3d Complement 3d, transplant rejection biomarker C4d Complement 4d, transplant rejection biomarker CD1a Cortical thymocytes-langerhans cells CD2 Lymphocyte function-associated antigen 2 CD3 (2VG6) T-Cells 2

CD4 T-Cells, Helper T CD5 Pan T-cells, B-cell subset, Thymic carcinomas CD7 Thymocytes, Immature t-cells, NK cells CD8 T-Cells, Suppressor T CD10 Common acute lymphoblastic leukemia CD14 Identify monocytes and histiocytes CD15 (MMA) Epithelial/Hodgkin s/myeloid CD19 B-Lymphocyte antigen CD20 Human B-lymphocyte antigen CD21 Dendritic cells, B-cells CD22 Mature B-cells CD23 Activated B-cells CD25 Activated T-cells and B-cells C30 (1G12) Ki-1: Activated T, B, RS cells CD31 Endothelium (tumor angiogenesis) CD33 Monocytes CD34 Endothelium, Stem cells, Stromal tumors CD35 Dendritic cells CD43 T-cells, B-cell subset, Myeloid, Histiocytes, Plasma cells (leukosialin) CD44 Phagocytic glycogen-1 CD45 Helper, Inducer T-cells CD56 Natural killer cells CD57 Neural and neuroendocrine marker NK cells, Stromal tumors CD61 GP111A CD68 (KP1) Sarcomas and leukemia CD68 (PG-M1) Monocytes/Macrophages CD71 Erythroid precursor marker CD79a B-cells CD99 Ewing s sarcoma/pnet CD117 C-kit CD123 Alpha receptor for IL3 CD138 Plasma cell marker, Syndecan CD163 Ber-MAC3 CDX-2 Metastatic colon CA CEA Carcinoembryonic antigen Chromogranin (CHROMO) Chromogranin A Clusterin Apoptosis Cyclin-D1 Cyclin D1/PRAD-1 oncogene product, Mantle cell Cytokeratin AE1/AE3 Keratin cocktail: 40, 48, 50, 50, 6, 58, 65, 5 kd Cytokeratin CAM5.2 Keratin: 39, 43, 500 kd Cytokeratin 5/6 Intermediate filament protein, Cytokeratin 5/6 Cytokeratin 7 Keratin: 54 kd Cytokeratin 19 Human cytokeratin 19 polypeptide Cytokeratin 20 Keratin: 54 kd Cytokeratin KER903 High molecular weight cytokeratins CMV Cytomegalovirus c-myc Lymphoma marker CXCL-13 B-Lymphocyte chemoattractant D2-40 Podoplanin, lymphatic endothelial marker 3

Desmin Desmin EBNA-2 s nuclei of EBV-infected lymphoblastoid cells DOG-1 GIST marker EBV Epstein-Barr virus E-cadherin (CADH) Epithelial marker EMA Epithelial membrane antigen Enolase (NSE) Neuron specific enolase EP4-Ber Epithelial antigen ERG Vascular marker and prostate malignancy marker ER Estrogen receptor Factor VIII Von Willebrand factor, Endotheium and megakaryocytes Factor XIII Fibrohistiocytic tumors, Dendritic interstitial cells Fascin Hodgkin s disease, High grade breast carcinoma FGFR3 CD333, Fibroblast growth factor receptor 3 FSH Follicle stimulating hormone Galectin Inflammation and cancer Gastrin Gastrin secreting tumors, G-cell hyperplasia GATA3 Urothelial carcinoma marker GCDFP-24 Gross cystic disease fluid protein-15 GCET1 Germinal center B-cell marker GFAP Human glial fibrillary acidic protein GH Growth hormone Glucagon Glucagon Glutamine Synthetase Hepatocellular carcinoma marker Glypican-3 Hepatocellular carcinoma marker Granzyme-B Serine protease Hemoglobin-A Hemoglobin-A HBcAg Hepatitis B core antigen HBsAg Hepatitis B surface antigen H-Caldesmon (HCAL) Smooth muscle differentiation H.pylori Helicobacter pylori ßHCG HCG in trophoblastic elements of germ cell tumors Hepatocyte Hep-par1 Herpes (HSVI&II) HSV I/II HER2 Neu (4B5) Erb-2 oncoprotein, Clone 4B5 HHV8 Human herpesvirus 8 HMB 45 Melanoma associated marker HPV Human papilloma virus subtype IDH-1 Glioma Marker IgA Immunoglobulin A IgD Immunoglobulin D IgG Immunoglobulin G IgG4 Autoimmune pancreatitis IgM Immunoglobulin M INI1 Malignant rhabdoid tumor marker Inhibin Granulosa cell tumor, Sex cord stromal tumor Insulin Insulin Ki67 Cell proliferation marker 4

Kappa Kappa light chain Lambda Lambda light chain Langerin Langerhans cell histiocytosis LEF1 Chronic lymphocytic (CLL)/small lymphocytic (SLL) leukemias LH Luteinizing hormone LMO2 Large B-cell lymphoma marker Mammaglobin Primary and metastatic breast carcinoma marker MDM2 Liposarcoma Melan A Malignant melanoma marker MiTF Melanocyte development regulator, melanoma oncogene MLH-1 Mismatch repair gene MLH-1 MOC-31 Differentiate carcinomas from mesothelial cells and mesotheliomas MSH-2 Mismatch repair gene MSH-2 MSH-6 Mismatch repair gene MSH-6 MUC-4 Fibromyxoid sarcoma MUM-1 Multiple myeloma oncogene-1 Muramidase Muramidase/Lysozyme Myeloperoxidase Neutrophilic granulocytes and monocytes MyoD1 Rhabdomyosarcoma marker Myogenin Rhabdomyosarcoma marker Napsin A Lung adenocarcinoma marker NeuN Neuronal cell loss in drug resistant epilepsy Neurofilament Neurofilament Neurofilament Cocktail Cocktail of clones 2F11 and SMI-32 NKI/C3 Melanoma marker NKX3.1 Differential marker for prostate carcinoma vs. urothelial carcinoma OCT-2 Octamer transcription factor 2 OCT3/4 Marker for undifferentiated cells p16 Cervical cancer marker p40 Pulmonary squamous cell carcinoma marker p53 Overexpression of the p53 oncogene p57 Differential diagnosis of complete vs partial hydatidiform molar pregnancy p63 Prostate cancer marker p63/erg Double A double stain for prostate cancer PAP Normal hyperplastic and neoplastic, Prostatic cells PAX-2 Tumor marker for kidney, prostate, breast, ovary PAX-5 B-cell specific activator protein PAX-8 Nephritic cell lineage marker Perforin T-cell and NK cell lymphoma PD1 T-cell regulator PDGFR oligodendrocytic progenitor cells PIN cocktail (p63&amacr) p63 and AMACR Prolactin Prolactin in pituitary PLAP Placental alkaline phosphatase, Germ cell and adenocarcinoma PMS2 Mismatch repair gene PMS-2 PR Progesterone receptor PSA Prostate specific antigen PSMA Prostate specific membrane antigen 5

PTH Parathyroid hormone Racemase (AMACR) Prostate adenocarcinoma marker S-100 S100 protein SALL4 Yolk sac tumor marker SF-1 Adrenocortical tumor marker SMMS1 Smooth muscle myosin SOX-10 Identify melanoma and nerve sheath tumors SOX-11 Mantle cell lymphoma marker pstat 5 Surrogate marker of JAK2 V617F mutation Synaptophysin Synaptophysin Syph T. pallidum SV40 Simian Virus 40, polyomavirus family Tau/Beta-amyloid DS Neurofibrillary tangle and amyloid in Alzheimer s postmortem specimens TCL-1A Mature T-cell leukemia TCR ß F1 T-cells TCR-Gamma T-cells TdT Blasts, Immature lymphocytes Thyroglobulin Thyroglobulin TIA Cytolytic effector cells in lymphocytic infiltrates Transthyretin osis Tryptase (MC trypt) Human mast cells TSH Thyrotropic cells of pituitary TTF-1 Thyroid and pulmonary carcinomas Tyrosinase Metastatic melanoma Ubiqutin Neurofibrillary tangles of Alzheimer s disease Vimentin Vimentin VS38C Plasma cell WT1 (6F-H2) Wilms tumor 14-3-3 14.3.3 Sigma, epithelial cell marker CISHs (+NEG & ALU or U6) CISH EBER Chromogenic in situ hybridization for EBV CISH Kappa Chromogenic in situ hybridization for Kappa CISH Lambda Chromogenic in situ hybridization for Lambda Every life deserves world class care. 9500 Euclid Avenue, Cleveland, OH 44195 Cleveland Clinic is an integrated healthcare delivery system with a main campus. 18 family health centers, eight community hospitals and locations in Ohio, Florida, Nevada, Toronto and Abu Dhabi. It is a not-for-profit group practice where nearly 3,000 staff physicians and scientists in 120 medical specialties collaborate to give every patient the best outcome and experience. Cleveland Clinic is ranked among America s top hospitals overall, and among the nation s leaders in every major medical specialty (U.S.News & World Report). clevelandclinic.org The Cleveland Clinic Foundation 2016 201602.003